
A three-year-old girl has become the youngest patient in the UK to receive a groundbreaking gene therapy for a rare, life-threatening inherited condition.
Gunreet Kaur, from Hayes in west London, underwent the pioneering treatment for aromatic l-amino acid decarboxylase (AADC) deficiency, a disorder that severely impacts children’s physical, mental, and behavioural development.